| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | AGO2 HNRNPK NOMO2 EEFSEC LETM2 USP16 NOMO1 MTOR CSNK2A1 LTN1 NOMO3 | 9.23e-06 | 206 | 204 | 11 | GO:0043021 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 9.77e-06 | 14 | 204 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 9.77e-06 | 14 | 204 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.03e-05 | 29 | 204 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.11e-05 | 210 | 204 | 11 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | DAB2IP PSG2 PSG4 PSG9 PSG11 PTK2 STAT1 STAT6 BOD1 NFATC2 MVP AKAP6 | 1.84e-05 | 264 | 204 | 12 | GO:0019902 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.32e-05 | 34 | 204 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 5.67e-05 | 8 | 204 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 5.67e-05 | 8 | 204 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 8.04e-05 | 70 | 204 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 8.04e-05 | 23 | 204 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.63e-04 | 11 | 204 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | filamin binding | 2.06e-04 | 29 | 204 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | ribosome binding | 2.35e-04 | 120 | 204 | 7 | GO:0043022 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.68e-04 | 31 | 204 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.88e-04 | 57 | 204 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulatory subunit binding | 3.52e-04 | 14 | 204 | 3 | GO:0036312 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.67e-04 | 60 | 204 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 4.15e-04 | 173 | 204 | 8 | GO:0070851 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 4.37e-04 | 15 | 204 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.32e-04 | 65 | 204 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.32e-04 | 65 | 204 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | mediator complex binding | 6.15e-04 | 4 | 204 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 6.15e-04 | 4 | 204 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | Rho GDP-dissociation inhibitor binding | 6.15e-04 | 4 | 204 | 2 | GO:0051022 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 6.15e-04 | 4 | 204 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 8.74e-04 | 42 | 204 | 4 | GO:0051721 | |
| GeneOntologyMolecularFunction | SUMO binding | 9.02e-04 | 19 | 204 | 3 | GO:0032183 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 9.06e-04 | 73 | 204 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 9.56e-04 | 43 | 204 | 4 | GO:0043548 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.02e-03 | 5 | 204 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | glycerol-3-phosphate O-acyltransferase activity | 1.02e-03 | 5 | 204 | 2 | GO:0004366 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 1.02e-03 | 5 | 204 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 1.02e-03 | 5 | 204 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.02e-03 | 75 | 204 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 1.05e-03 | 20 | 204 | 3 | GO:0061608 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.15e-03 | 77 | 204 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.34e-03 | 207 | 204 | 8 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.38e-03 | 208 | 204 | 8 | GO:0005342 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 1.52e-03 | 6 | 204 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.52e-03 | 6 | 204 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 1.52e-03 | 6 | 204 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.56e-03 | 49 | 204 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.56e-03 | 49 | 204 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 2.04e-03 | 128 | 204 | 6 | GO:0032182 | |
| GeneOntologyMolecularFunction | GDP-dissociation inhibitor binding | 2.11e-03 | 7 | 204 | 2 | GO:0051021 | |
| GeneOntologyMolecularFunction | uridylyltransferase activity | 2.11e-03 | 7 | 204 | 2 | GO:0070569 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 2.11e-03 | 7 | 204 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.31e-03 | 90 | 204 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRG2 TMC6 CHRNA5 RYR1 RYR3 CHRNE SCN1A GRIN2A GRIN2C CACNA2D3 | 2.37e-03 | 334 | 204 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 2.57e-03 | 27 | 204 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 2.79e-03 | 8 | 204 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 2.79e-03 | 8 | 204 | 2 | GO:0101021 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 2.79e-03 | 8 | 204 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 3.19e-03 | 140 | 204 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.27e-03 | 293 | 204 | 9 | GO:0008514 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.64e-03 | 100 | 204 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.76e-03 | 193 | 204 | 7 | GO:0015276 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | GABRG2 PSG2 PSG4 PDK4 PSG9 PSG11 SREBF1 CHRNA5 PTK2 STAT1 RYR1 HNRNPK RYR3 CHRNE STAT6 GRK2 XRN1 RAC1 DNM2 AKAP6 GPAM GRIN2A CPS1 DENND4C MTOR | 1.09e-07 | 752 | 203 | 25 | GO:1901699 |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | PSG2 PSG4 PDK4 PSG9 PSG11 SREBF1 PTK2 STAT1 HNRNPK STAT6 GRK2 RAC1 GPAM CPS1 DENND4C MTOR | 1.26e-06 | 381 | 203 | 16 | GO:0071375 |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 2.11e-06 | 86 | 203 | 8 | GO:0042058 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 3.82e-06 | 93 | 203 | 8 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 8.44e-06 | 14 | 203 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 9.87e-06 | 139 | 203 | 9 | GO:0007173 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.14e-05 | 15 | 203 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.14e-05 | 15 | 203 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.14e-05 | 15 | 203 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.14e-05 | 15 | 203 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | DAB2IP NUGGC ERN1 PSG2 PSG4 PDK4 PSG9 PSG11 SREBF1 CHRNA5 PTK2 STAT1 RYR1 HNRNPK RYR3 CHRNE STAT6 MALT1 GRK2 XRN1 PLEC RAC1 DNM2 DNMT1 AKAP6 TUT4 GPAM GRIN2A CPS1 DENND4C POSTN MTOR | 1.41e-05 | 1450 | 203 | 32 | GO:1901701 |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.51e-05 | 16 | 203 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | PSG2 PSG4 PDK4 PSG9 PSG11 SREBF1 STAT1 HNRNPK GRK2 GPAM DENND4C MTOR | 1.65e-05 | 271 | 203 | 12 | GO:0032869 |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.94e-05 | 34 | 203 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.96e-05 | 17 | 203 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.96e-05 | 17 | 203 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.96e-05 | 17 | 203 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium organization | 2.02e-05 | 57 | 203 | 6 | GO:1902743 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.24e-05 | 35 | 203 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.50e-05 | 18 | 203 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.99e-05 | 61 | 203 | 6 | GO:0060259 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 3.04e-05 | 160 | 203 | 9 | GO:0038127 | |
| GeneOntologyBiologicalProcess | bone remodeling | 3.78e-05 | 127 | 203 | 8 | GO:0046849 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.90e-05 | 20 | 203 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | circulatory system process | PSG2 PSG4 PSG9 PSG11 SREBF1 PTK2 STAT1 DOCK5 GRK2 AMOT SCN1A PLEC KLK2 RAC1 AKAP6 E2F4 CPS1 POSTN MTOR SLC22A3 | 3.95e-05 | 733 | 203 | 20 | GO:0003013 |
| GeneOntologyBiologicalProcess | positive regulation of lamellipodium organization | 4.37e-05 | 40 | 203 | 5 | GO:1902745 | |
| GeneOntologyBiologicalProcess | regulation of substrate adhesion-dependent cell spreading | 4.69e-05 | 66 | 203 | 6 | GO:1900024 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 4.78e-05 | 21 | 203 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 4.78e-05 | 21 | 203 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 4.78e-05 | 21 | 203 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | mycotoxin metabolic process | 5.07e-05 | 8 | 203 | 3 | GO:0043385 | |
| GeneOntologyBiologicalProcess | aflatoxin metabolic process | 5.07e-05 | 8 | 203 | 3 | GO:0046222 | |
| GeneOntologyBiologicalProcess | organic heteropentacyclic compound metabolic process | 5.07e-05 | 8 | 203 | 3 | GO:1901376 | |
| GeneOntologyBiologicalProcess | bone resorption | 5.59e-05 | 99 | 203 | 7 | GO:0045453 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 5.80e-05 | 22 | 203 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.97e-05 | 23 | 203 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 6.97e-05 | 23 | 203 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 7.10e-05 | 71 | 203 | 6 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | PSG2 PSG4 PDK4 PSG9 PSG11 SREBF1 PTK2 STAT1 HNRNPK STAT6 GRK2 RAC1 GPAM CPS1 DENND4C MTOR | 7.54e-05 | 530 | 203 | 16 | GO:0043434 |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 7.55e-05 | 9 | 203 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | blood circulation | PSG2 PSG4 PSG9 PSG11 SREBF1 PTK2 STAT1 DOCK5 GRK2 AMOT SCN1A PLEC KLK2 AKAP6 E2F4 CPS1 POSTN MTOR | 7.78e-05 | 648 | 203 | 18 | GO:0008015 |
| GeneOntologyBiologicalProcess | regulation of lamellipodium assembly | 7.80e-05 | 45 | 203 | 5 | GO:0010591 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 8.29e-05 | 24 | 203 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 8.29e-05 | 24 | 203 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 8.29e-05 | 24 | 203 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 8.30e-05 | 73 | 203 | 6 | GO:0042304 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 9.64e-05 | 47 | 203 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 9.64e-05 | 47 | 203 | 5 | GO:0034104 | |
| GeneOntologyBiologicalProcess | virus maturation | 9.64e-05 | 2 | 203 | 2 | GO:0019075 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 9.80e-05 | 25 | 203 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 9.80e-05 | 25 | 203 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.34e-04 | 27 | 203 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | GABRG2 CLGN ERN1 PSG2 PSG4 PDK4 PSG9 PSG11 SREBF1 CHRNA5 PTK2 STAT1 RYR1 HNRNPK RYR3 CHRNE STAT6 GRK2 XRN1 RAC1 DNM2 AKAP6 GPAM GRIN2A CPS1 DENND4C MTOR | 1.36e-04 | 1272 | 203 | 27 | GO:1901698 |
| GeneOntologyBiologicalProcess | response to insulin | PSG2 PSG4 PDK4 PSG9 PSG11 SREBF1 STAT1 HNRNPK GRK2 GPAM DENND4C MTOR | 1.55e-04 | 342 | 203 | 12 | GO:0032868 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.55e-04 | 28 | 203 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | PSG2 PSG4 PSG9 PSG11 PTK2 DOCK5 GRK2 AMOT PLEC KLK2 CPS1 SLC22A3 | 1.63e-04 | 344 | 203 | 12 | GO:0003018 |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 1.70e-04 | 246 | 203 | 10 | GO:0046890 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.78e-04 | 29 | 203 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 1.82e-04 | 248 | 203 | 10 | GO:0120032 | |
| GeneOntologyBiologicalProcess | circulatory system development | DAB2IP AGO2 PSG2 PSG4 PSG9 PSG11 PTK2 STAT1 RYR1 GRK2 NFATC2 AMOT FLRT2 PLEC KLK2 NIPBL NAXE RAC1 DNM2 DNMT1 AKAP6 ABI3BP ADAMTS1 SALL4 APOB LLGL2 IFT88 MTOR TP53BP2 | 1.90e-04 | 1442 | 203 | 29 | GO:0072359 |
| GeneOntologyBiologicalProcess | alditol phosphate metabolic process | 1.94e-04 | 12 | 203 | 3 | GO:0052646 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 2.00e-04 | 251 | 203 | 10 | GO:0060491 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 2.19e-04 | 123 | 203 | 7 | GO:0120034 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.33e-04 | 31 | 203 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | cell junction organization | DAB2IP GABRG2 AGO2 PSG2 PSG4 PSG9 PSG11 CORO1C PTK2 HNRNPK PTPN13 FLRT2 PLEC RAC1 NPHS1 ABI3BP PCDHB3 LINGO2 GRIN2A DNM3 PDZRN3 CACNA2D3 | 2.52e-04 | 974 | 203 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 2.61e-04 | 212 | 203 | 9 | GO:0000070 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.64e-04 | 32 | 203 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | positive regulation of lamellipodium assembly | 2.64e-04 | 32 | 203 | 4 | GO:0010592 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 2.64e-04 | 32 | 203 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.64e-04 | 32 | 203 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | protein catabolic process | DAB2IP UBL7 CLGN ERN1 PSG2 PSG4 PSG9 PSG11 PTK2 MALT1 MVB12A HERC2 MVB12B APOB GRIN2A GRIN2C CHMP4B TBL1XR1 MTOR CSNK2A1 MTM1 LTN1 RPGR CSNK2A3 | 2.67e-04 | 1115 | 203 | 24 | GO:0030163 |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.98e-04 | 33 | 203 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.98e-04 | 33 | 203 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | BOD1 NCAPG NIPBL INO80 CHMP4B USP16 SMC3 ARHGEF10 HASPIN MTBP ESPL1 | 3.11e-04 | 316 | 203 | 11 | GO:0140014 |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 3.35e-04 | 34 | 203 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 3.55e-04 | 221 | 203 | 9 | GO:0006469 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CORO1C KIAA0586 LRRC43 ZMYND10 PLXNB3 RAC1 RAC2 WDR44 DNM2 SPATA6 E2F4 IFT88 MTOR DNM3 RPGR HYDIN TCTN2 | 3.56e-04 | 670 | 203 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | DAB2IP PSG2 PSG4 PSG9 PSG11 CORO1C PTPN13 GRK2 PLEC MVP RGS14 MTOR | 3.59e-04 | 375 | 203 | 12 | GO:0001933 |
| GeneOntologyBiologicalProcess | organelle assembly | AGO2 KIAA0586 LRRC43 DDX6 DOCK5 MVB12A ZMYND10 PIK3C3 PLEC WDR44 DNM2 SPATA6 ABI3BP E2F4 INO80 CHMP4B IFT88 SMC3 ARHGEF10 MTOR MTM1 RPGR HYDIN TCTN2 | 3.60e-04 | 1138 | 203 | 24 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 3.69e-04 | 134 | 203 | 7 | GO:0019217 | |
| GeneOntologyBiologicalProcess | virion assembly | 3.76e-04 | 35 | 203 | 4 | GO:0019068 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 4.19e-04 | 36 | 203 | 4 | GO:0007064 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | DAB2IP PSG2 PSG4 PSG9 PSG11 PTK2 PTPN13 PIK3C3 KLK2 RAC1 MTOR MTM1 | 4.23e-04 | 382 | 203 | 12 | GO:0043491 |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell proliferation | 4.41e-04 | 138 | 203 | 7 | GO:0048661 | |
| GeneOntologyBiologicalProcess | lamellipodium organization | 4.42e-04 | 99 | 203 | 6 | GO:0097581 | |
| GeneOntologyBiologicalProcess | cell projection assembly | CORO1C KIAA0586 LRRC43 ZMYND10 PLXNB3 RAC1 RAC2 WDR44 DNM2 SPATA6 E2F4 IFT88 MTOR DNM3 RPGR HYDIN TCTN2 | 4.58e-04 | 685 | 203 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | DAB2IP AGO2 ERN1 PSG2 PSG4 PSG9 PSG11 CORO1C BIRC6 DDX6 BOD1 PTPN13 GRK2 XRN1 PLEC MVP GRIN2A GRIN2C RGS14 MTOR CSNK2A1 MTM1 MVK | 4.64e-04 | 1088 | 203 | 23 | GO:0051248 |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | IL12RB1 PSG2 PSG4 PSG9 PSG11 PTK2 STAT6 NFATC2 TMEM131L RAC2 GPAM | 4.71e-04 | 332 | 203 | 11 | GO:0070663 |
| GeneOntologyBiologicalProcess | protein localization to organelle | SREBF1 ARL5C BOD1 GRK2 MVB12A BRCA2 ZMYND10 NOMO2 PIK3C3 NIPBL RAC2 KPNA2 KPNA3 KPNA4 GRIN2A CHMP4B NOMO1 MTOR HASPIN MTBP NOMO3 TP53BP1 TCTN2 | 4.82e-04 | 1091 | 203 | 23 | GO:0033365 |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 4.96e-04 | 334 | 203 | 11 | GO:0051896 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 5.17e-04 | 38 | 203 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 5.18e-04 | 67 | 203 | 5 | GO:0007062 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | PSG2 PSG4 PSG9 PSG11 HNRNPK GRK2 DMBT1 RAC1 DNM2 DNAJC13 DNM3 | 5.34e-04 | 337 | 203 | 11 | GO:0006898 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.44e-04 | 187 | 203 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of kinase activity | 5.71e-04 | 236 | 203 | 9 | GO:0033673 | |
| GeneOntologyBiologicalProcess | viral penetration into host nucleus | 5.71e-04 | 4 | 203 | 2 | GO:0075732 | |
| GeneOntologyBiologicalProcess | bone regeneration | 5.71e-04 | 4 | 203 | 2 | GO:1990523 | |
| GeneOntologyBiologicalProcess | directional locomotion | 5.71e-04 | 4 | 203 | 2 | GO:0033058 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 5.72e-04 | 39 | 203 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | inner cell mass cell proliferation | 5.77e-04 | 17 | 203 | 3 | GO:0001833 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.49e-05 | 16 | 205 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 7.47e-05 | 9 | 205 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | AIP1-IRE1 complex | 9.57e-05 | 2 | 205 | 2 | GO:1990597 | |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 1.06e-04 | 10 | 205 | 3 | GO:0042564 | |
| GeneOntologyCellularComponent | sarcolemma | 1.12e-04 | 190 | 205 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.64e-04 | 157 | 205 | 8 | GO:1902554 | |
| GeneOntologyCellularComponent | glutamatergic synapse | GABRG2 AGO2 TRIO ABHD6 PTK2 HNRNPK GRK2 PIK3C3 FLRT2 SIPA1L2 RAC1 DNM2 KPNA2 GRIN2A GRIN2C CHMP4B RGS14 PPP2R1B MTOR DNM3 | 1.65e-04 | 817 | 205 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 1.92e-04 | 12 | 205 | 3 | GO:0031074 | |
| GeneOntologyCellularComponent | anchoring junction | PSG2 PSG4 PSG9 PSG11 CORO1C PTK2 HNRNPK DDX6 DOCK5 AMOT AHNAK SCN1A NHS FLRT2 PLEC RAC1 RAC2 DNM2 AKAP6 NPHS1 PARD3B LLGL2 | 2.48e-04 | 976 | 205 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | protein kinase complex | 2.82e-04 | 170 | 205 | 8 | GO:1902911 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.12e-04 | 14 | 205 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | postsynapse | GABRG2 AGO2 TRIO ABHD6 CHRNA5 PTK2 HNRNPK CHRNE GRK2 PIK3C3 SORCS2 FLRT2 RAC1 DNM2 KPNA2 ABI3BP GRIN2A GRIN2C CHMP4B RGS14 MTOR DNM3 | 4.42e-04 | 1018 | 205 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | lamellipodium | 4.62e-04 | 230 | 205 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | cilium | PSG2 PSG4 PSG9 PSG11 KIAA0586 LRRC43 PTK2 DDX6 GRK2 PIK3C3 DNAH9 NAXE RAC1 SPATA6 CFAP210 PRAMEF8 IFT88 RPGR HYDIN TCTN2 | 5.57e-04 | 898 | 205 | 20 | GO:0005929 |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 5.67e-04 | 4 | 205 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | dendritic spine | 6.66e-04 | 242 | 205 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | cell-cell junction | PSG2 PSG4 PSG9 PSG11 PTK2 DDX6 AMOT AHNAK SCN1A NHS FLRT2 AKAP6 NPHS1 PARD3B LLGL2 | 7.63e-04 | 591 | 205 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | neuron spine | 7.71e-04 | 247 | 205 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GABRG2 CORO1C TMC6 ABHD6 SREBF1 MVB12A PIK3C3 SORCS2 DMBT1 FER1L5 RAC1 RAC2 WDR44 DNM2 DOP1B MVB12B DMXL2 DNAJC13 VPS39 ABCC11 APOB GRIN2A CHMP4B DENND4C IFT88 | 1.06e-03 | 1307 | 205 | 25 | GO:0030659 |
| GeneOntologyCellularComponent | T-tubule | 1.08e-03 | 79 | 205 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | integrator complex | 1.09e-03 | 21 | 205 | 3 | GO:0032039 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC7A13 PSG2 PSG4 PSG9 PSG11 PTK2 GRK2 ZMYND10 NHS PLEC ABCC11 PARD3B SLC22A3 | 1.09e-03 | 487 | 205 | 13 | GO:0016324 |
| GeneOntologyCellularComponent | vesicle membrane | GABRG2 CORO1C TMC6 ABHD6 SREBF1 MVB12A PIK3C3 SORCS2 DMBT1 FER1L5 RAC1 RAC2 WDR44 DNM2 DOP1B MVB12B DMXL2 DNAJC13 VPS39 ABCC11 APOB GRIN2A CHMP4B DENND4C IFT88 | 1.28e-03 | 1325 | 205 | 25 | GO:0012506 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRG2 ABHD6 CHRNA5 RYR1 RYR3 CHRNE SCN1A AKAP6 GRIN2A GRIN2C CACNA2D3 | 1.32e-03 | 378 | 205 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.40e-03 | 269 | 205 | 9 | GO:0036464 | |
| GeneOntologyCellularComponent | centrosome | KIAA0586 MDH1 BIRC6 PTK2 BOD1 MVB12A BRCA2 ZMYND10 CEP95 RAC1 DNM2 RGS14 IFT88 ARHGEF10 HASPIN RPGR ESPL1 | 1.59e-03 | 770 | 205 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | membrane protein complex | GABRG2 IL12RB1 ERN1 PSG2 PSG4 PSG9 PSG11 CORO1C ABHD6 CHRNA5 RYR1 RYR3 CHRNE MVB12A PIK3C3 AHNAK SCN1A RAC1 RAC2 MVB12B AKAP6 VPS39 GRIN2A GRIN2C CHMP4B DENND4C CACNA2D3 | 1.60e-03 | 1498 | 205 | 27 | GO:0098796 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.93e-03 | 90 | 205 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | IL12RB1 PSG2 PSG4 PSG9 PSG11 CORO1C ABHD6 CHRNA5 RYR1 CHRNE AHNAK SCN1A RAC1 RAC2 GRIN2A GRIN2C CACNA2D3 | 1.95e-03 | 785 | 205 | 17 | GO:0098797 |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.18e-03 | 287 | 205 | 9 | GO:0035770 | |
| GeneOntologyCellularComponent | apical part of cell | SLC7A13 PSG2 PSG4 PSG9 PSG11 PTK2 GRK2 ZMYND10 NHS PLEC KLK2 ABCC11 PARD3B SLC22A3 | 2.20e-03 | 592 | 205 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRG2 ABHD6 CHRNA5 CHRNE SORCS2 FLRT2 RAC1 DNM2 GRIN2A GRIN2C DNM3 | 2.27e-03 | 405 | 205 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | IL12RB1 PSG2 PSG4 PSG9 PSG11 ABHD6 CHRNA5 CHRNE GRIN2A GRIN2C | 2.48e-03 | 350 | 205 | 10 | GO:0098802 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CYP2C19 CLGN ERN1 CYP3A4 CYP3A5 TMC6 SREBF1 ERGIC2 RYR1 RYR3 CYP2W1 NOMO2 FLRT2 RAC1 RAC2 KPNA2 AKAP6 APOB GRIN2A GRIN2C NOMO1 MTOR SLC22A3 NOMO3 | 2.80e-03 | 1327 | 205 | 24 | GO:0042175 |
| GeneOntologyCellularComponent | ciliary membrane | 2.81e-03 | 98 | 205 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | supramolecular fiber | CORO1C RYR1 RYR3 KRT80 DDX6 BOD1 AMOT AHNAK SCN1A PLEC DNAH9 RAC1 RAC2 WDR44 DNM2 CFAP210 INO80 CHMP4B RGS14 MTM1 DNM3 LUM | 2.89e-03 | 1179 | 205 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CORO1C RYR1 RYR3 KRT80 DDX6 BOD1 AMOT AHNAK SCN1A PLEC DNAH9 RAC1 RAC2 WDR44 DNM2 CFAP210 INO80 CHMP4B RGS14 MTM1 DNM3 LUM | 3.13e-03 | 1187 | 205 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | host cell | 3.29e-03 | 9 | 205 | 2 | GO:0043657 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 3.29e-03 | 9 | 205 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | junctional membrane complex | 3.29e-03 | 9 | 205 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | focal adhesion | CORO1C PTK2 HNRNPK AHNAK NHS FLRT2 PLEC RAC1 RAC2 DNM2 NPHS1 | 3.65e-03 | 431 | 205 | 11 | GO:0005925 |
| GeneOntologyCellularComponent | nuclear envelope | ERN1 TMC6 SREBF1 MVP RAC2 KPNA2 KPNA3 AKAP6 KPNA4 CHMP4B MTOR SLC22A3 WDFY3 | 3.67e-03 | 560 | 205 | 13 | GO:0005635 |
| GeneOntologyCellularComponent | ESCRT complex | 3.74e-03 | 32 | 205 | 3 | GO:0036452 | |
| GeneOntologyCellularComponent | cell leading edge | GABRG2 CORO1C PTK2 PTPN13 AMOT NHS RAC1 RAC2 DNM2 ABI3BP GRIN2A MTM1 | 3.98e-03 | 500 | 205 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 4.09e-03 | 10 | 205 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | postsynaptic specialization | GABRG2 CHRNE GRK2 SORCS2 DNM2 KPNA2 ABI3BP GRIN2A GRIN2C CHMP4B RGS14 DNM3 | 4.18e-03 | 503 | 205 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CYP2C19 CLGN ERN1 CYP3A4 CYP3A5 TMC6 SREBF1 ERGIC2 RYR1 RYR3 CYP2W1 NOMO2 FLRT2 RAC1 RAC2 KPNA2 AKAP6 APOB GRIN2A GRIN2C NOMO1 MTOR NOMO3 | 4.19e-03 | 1293 | 205 | 23 | GO:0005789 |
| GeneOntologyCellularComponent | microtubule organizing center | KIAA0586 MDH1 BIRC6 PTK2 BOD1 MVB12A BRCA2 ZMYND10 CEP95 HERC2 RAC1 DNM2 RGS14 IFT88 ARHGEF10 HASPIN RPGR ESPL1 | 4.21e-03 | 919 | 205 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CYP2C19 CLGN ERN1 CYP3A4 CYP3A5 TMC6 SREBF1 ERGIC2 RYR1 RYR3 CYP2W1 NOMO2 FLRT2 RAC1 RAC2 KPNA2 AKAP6 APOB GRIN2A GRIN2C NOMO1 MTOR NOMO3 | 4.43e-03 | 1299 | 205 | 23 | GO:0098827 |
| GeneOntologyCellularComponent | cell-substrate junction | CORO1C PTK2 HNRNPK AHNAK NHS FLRT2 PLEC RAC1 RAC2 DNM2 NPHS1 | 4.47e-03 | 443 | 205 | 11 | GO:0030055 |
| GeneOntologyCellularComponent | dendrite | DAB2IP GABRG2 AGO2 CHRNA5 PTK2 STAT1 HNRNPK GRK2 XRN1 SORCS2 PLEC RAC1 ABI3BP GRIN2A RGS14 MTOR DNM3 | 4.80e-03 | 858 | 205 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP GABRG2 AGO2 CHRNA5 PTK2 STAT1 HNRNPK GRK2 XRN1 SORCS2 PLEC RAC1 ABI3BP GRIN2A RGS14 MTOR DNM3 | 4.91e-03 | 860 | 205 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | receptor complex | GABRG2 IL12RB1 PSG2 PSG4 PSG9 PSG11 ABHD6 CRLF2 CHRNA5 CHRNE PLXNB3 GRIN2A GRIN2C | 4.97e-03 | 581 | 205 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | adherens junction | 5.03e-03 | 212 | 205 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRG2 ABHD6 CHRNA5 CHRNE SCN1A SORCS2 FLRT2 RAC1 DNM2 GRIN2A GRIN2C DNM3 CACNA2D3 | 5.12e-03 | 583 | 205 | 13 | GO:0097060 |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 4.14e-05 | 17 | 167 | 4 | MP:0031047 | |
| MousePheno | embryonic lethality between implantation and placentation | AGO2 CDK12 PTK2 DDX6 BRCA2 PIK3C3 FKTN AMOT DMBT1 RAC1 DNAJC13 VPS39 SALL4 INO80 CHMP4B USP16 MTOR MTBP ESPL1 | 4.54e-05 | 565 | 167 | 19 | MP:0009850 |
| MousePheno | decreased muscle weight | 4.82e-05 | 34 | 167 | 5 | MP:0004232 | |
| Domain | ARM-type_fold | MROH5 RYR3 DOCK5 NCAPG PIK3C3 UTP20 NIPBL KPNA2 KPNA3 KPNA4 DNAJC13 APOB RALGAPA2 PPP2R1B MTOR LTN1 WDFY3 | 1.64e-07 | 339 | 201 | 17 | IPR016024 |
| Domain | - | IL12RB1 TRIO PSG2 PSG4 PSG7 PSG9 PSG11 CRLF2 MALT1 NFATC2 NOMO2 FLRT2 PLXNB3 NPHS1 MXRA5 ABI3BP IGDCC3 LINGO2 NOMO1 IGSF1 BTNL9 NOMO3 | 2.93e-06 | 663 | 201 | 22 | 2.60.40.10 |
| Domain | DUF2012 | 4.87e-06 | 4 | 201 | 3 | PF09430 | |
| Domain | DUF2012 | 4.87e-06 | 4 | 201 | 3 | IPR019008 | |
| Domain | Ig-like_fold | IL12RB1 TRIO PSG2 PSG4 PSG7 PSG9 PSG11 CRLF2 MALT1 NFATC2 NOMO2 FLRT2 PLXNB3 NPHS1 MXRA5 ABI3BP IGDCC3 LINGO2 NOMO1 IGSF1 BTNL9 NOMO3 | 7.96e-06 | 706 | 201 | 22 | IPR013783 |
| Domain | IGc2 | TRIO PSG2 PSG4 PSG7 PSG9 PSG11 MALT1 NPHS1 MXRA5 IGDCC3 LINGO2 IGSF1 | 9.53e-06 | 235 | 201 | 12 | SM00408 |
| Domain | Ig_sub2 | TRIO PSG2 PSG4 PSG7 PSG9 PSG11 MALT1 NPHS1 MXRA5 IGDCC3 LINGO2 IGSF1 | 9.53e-06 | 235 | 201 | 12 | IPR003598 |
| Domain | Ig_2 | 1.35e-05 | 73 | 201 | 7 | PF13895 | |
| Domain | - | MROH5 NCAPG UTP20 NIPBL KPNA2 KPNA3 KPNA4 DNAJC13 PPP2R1B MTOR WDFY3 | 2.98e-05 | 222 | 201 | 11 | 1.25.10.10 |
| Domain | ARM-like | MROH5 NCAPG UTP20 NIPBL KPNA2 KPNA3 KPNA4 DNAJC13 PPP2R1B MTOR LTN1 WDFY3 | 3.77e-05 | 270 | 201 | 12 | IPR011989 |
| Domain | Arm_3 | 4.16e-05 | 7 | 201 | 3 | PF16186 | |
| Domain | Importing_su_alpha | 4.16e-05 | 7 | 201 | 3 | IPR024931 | |
| Domain | IBB | 4.16e-05 | 7 | 201 | 3 | PF01749 | |
| Domain | Arm_3 | 4.16e-05 | 7 | 201 | 3 | IPR032413 | |
| Domain | IBB | 6.61e-05 | 8 | 201 | 3 | PS51214 | |
| Domain | Carb-bd-like_fold | 6.61e-05 | 8 | 201 | 3 | IPR013784 | |
| Domain | Importin-a_IBB | 9.83e-05 | 9 | 201 | 3 | IPR002652 | |
| Domain | DUF2464 | 1.15e-04 | 2 | 201 | 2 | PF10240 | |
| Domain | MVB12A/B | 1.15e-04 | 2 | 201 | 2 | IPR018798 | |
| Domain | ig | 2.22e-04 | 190 | 201 | 9 | PF00047 | |
| Domain | Immunoglobulin | 2.22e-04 | 190 | 201 | 9 | IPR013151 | |
| Domain | CarboxyPept_regulatory_dom | 3.24e-04 | 13 | 201 | 3 | IPR014766 | |
| Domain | - | 3.24e-04 | 13 | 201 | 3 | 2.60.40.1120 | |
| Domain | Ryanodine_rcpt | 3.43e-04 | 3 | 201 | 2 | IPR003032 | |
| Domain | NMDAR2_C | 3.43e-04 | 3 | 201 | 2 | PF10565 | |
| Domain | Ryanrecept_TM4-6 | 3.43e-04 | 3 | 201 | 2 | IPR009460 | |
| Domain | RyR | 3.43e-04 | 3 | 201 | 2 | PF02026 | |
| Domain | NMDAR2_C | 3.43e-04 | 3 | 201 | 2 | IPR018884 | |
| Domain | RR_TM4-6 | 3.43e-04 | 3 | 201 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.43e-04 | 3 | 201 | 2 | IPR013333 | |
| Domain | GPAT/DHAPAT | 3.43e-04 | 3 | 201 | 2 | IPR022284 | |
| Domain | HEAT | 3.96e-04 | 58 | 201 | 5 | IPR000357 | |
| Domain | Dynamin_GTPase | 5.08e-04 | 15 | 201 | 3 | IPR001401 | |
| Domain | Dynamin_SF | 5.08e-04 | 15 | 201 | 3 | IPR022812 | |
| Domain | Dynamin_N | 5.08e-04 | 15 | 201 | 3 | PF00350 | |
| Domain | IG | TRIO PSG2 PSG4 PSG7 PSG9 PSG11 MALT1 NPHS1 MXRA5 IGDCC3 LINGO2 IGSF1 BTNL9 | 6.64e-04 | 421 | 201 | 13 | SM00409 |
| Domain | Ig_sub | TRIO PSG2 PSG4 PSG7 PSG9 PSG11 MALT1 NPHS1 MXRA5 IGDCC3 LINGO2 IGSF1 BTNL9 | 6.64e-04 | 421 | 201 | 13 | IPR003599 |
| Domain | MABP | 6.82e-04 | 4 | 201 | 2 | PS51498 | |
| Domain | MABP | 6.82e-04 | 4 | 201 | 2 | IPR023341 | |
| Domain | CarboxyPept-like_regulatory | 7.47e-04 | 17 | 201 | 3 | IPR008969 | |
| Domain | HEAT_REPEAT | 9.43e-04 | 70 | 201 | 5 | PS50077 | |
| Domain | UMA | 1.13e-03 | 5 | 201 | 2 | PS51497 | |
| Domain | UMA | 1.13e-03 | 5 | 201 | 2 | IPR023340 | |
| Domain | Cyt_P450_E_grp-II | 1.13e-03 | 5 | 201 | 2 | IPR002402 | |
| Domain | Dynamin_central | 1.68e-03 | 6 | 201 | 2 | IPR000375 | |
| Domain | Cyt_P450_E_CYP3A | 1.68e-03 | 6 | 201 | 2 | IPR008072 | |
| Domain | RIH_assoc-dom | 1.68e-03 | 6 | 201 | 2 | IPR013662 | |
| Domain | GED | 1.68e-03 | 6 | 201 | 2 | SM00302 | |
| Domain | Dynamin_M | 1.68e-03 | 6 | 201 | 2 | PF01031 | |
| Domain | GED_dom | 1.68e-03 | 6 | 201 | 2 | IPR020850 | |
| Domain | Ins145_P3_rec | 1.68e-03 | 6 | 201 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.68e-03 | 6 | 201 | 2 | PF08454 | |
| Domain | RIH_dom | 1.68e-03 | 6 | 201 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.68e-03 | 6 | 201 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.68e-03 | 6 | 201 | 2 | IPR015925 | |
| Domain | GED | 1.68e-03 | 6 | 201 | 2 | PS51388 | |
| Domain | - | 1.68e-03 | 6 | 201 | 2 | 1.25.10.30 | |
| Domain | Dynamin_GTPase_CS | 1.68e-03 | 6 | 201 | 2 | IPR019762 | |
| Domain | RYDR_ITPR | 1.68e-03 | 6 | 201 | 2 | PF01365 | |
| Domain | GED | 1.68e-03 | 6 | 201 | 2 | PF02212 | |
| Domain | GED | 1.68e-03 | 6 | 201 | 2 | IPR003130 | |
| Domain | Kinase-like_dom | ERN1 TRIO CDK12 STK35 PTK2 PTPN13 GRK2 PIK3C3 DNM2 MTOR CSNK2A1 HASPIN DNM3 CSNK2A3 | 2.27e-03 | 542 | 201 | 14 | IPR011009 |
| Domain | STAT_TF_DNA-bd_sub | 2.34e-03 | 7 | 201 | 2 | IPR012345 | |
| Domain | STAT | 2.34e-03 | 7 | 201 | 2 | IPR001217 | |
| Domain | STAT_int | 2.34e-03 | 7 | 201 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 2.34e-03 | 7 | 201 | 2 | IPR013801 | |
| Domain | STAT_bind | 2.34e-03 | 7 | 201 | 2 | PF02864 | |
| Domain | STAT_int | 2.34e-03 | 7 | 201 | 2 | PF02865 | |
| Domain | - | 2.34e-03 | 7 | 201 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 2.34e-03 | 7 | 201 | 2 | PF01017 | |
| Domain | - | 2.34e-03 | 7 | 201 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 2.34e-03 | 7 | 201 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 2.34e-03 | 7 | 201 | 2 | IPR015988 | |
| Domain | - | 2.34e-03 | 7 | 201 | 2 | 2.60.40.630 | |
| Domain | G_DYNAMIN_1 | 2.34e-03 | 7 | 201 | 2 | PS00410 | |
| Domain | DYNc | 2.34e-03 | 7 | 201 | 2 | SM00053 | |
| Domain | LRRNT | 2.53e-03 | 53 | 201 | 4 | PF01462 | |
| Domain | Cyt_P450_CS | 2.53e-03 | 53 | 201 | 4 | IPR017972 | |
| Domain | IG_LIKE | TRIO PSG2 PSG4 PSG7 PSG9 PSG11 MALT1 NPHS1 MXRA5 IGDCC3 LINGO2 IGSF1 BTNL9 | 2.62e-03 | 491 | 201 | 13 | PS50835 |
| Pathway | WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN | 6.40e-05 | 21 | 150 | 4 | M48342 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 7.90e-05 | 42 | 150 | 5 | M27172 | |
| Pathway | REACTOME_XENOBIOTICS | 9.32e-05 | 23 | 150 | 4 | M5372 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 9.46e-05 | 9 | 150 | 3 | MM15059 | |
| Pubmed | TRIO CORO1C MDH1 PTK2 STAT1 HNRNPK RYR3 STAT6 PTPN13 NOMO2 PLEC HERC2 MVP NIPBL PLXNB3 DNM2 DNMT1 DOP1B KPNA3 AKAP6 KPNA4 DMXL2 ADAMTS1 VPS39 USP16 IFT88 ARHGEF10 MTM1 DNM3 WDFY3 USPL1 | 3.34e-11 | 1285 | 206 | 31 | 35914814 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP CLGN UBAP2 DOCK5 PTPN13 ZMYND10 AMOT AHNAK PLEC RAC1 DNM2 KPNA3 KPNA4 DNAJC13 E2F4 DENND4C NOMO1 POSTN IFT88 SMC3 PRPF3 MTOR CSNK2A1 XPNPEP3 AGMAT FUCA1 RPGR LUM TP53BP1 TP53BP2 TCTN2 | 6.62e-11 | 1321 | 206 | 31 | 27173435 |
| Pubmed | 3.83e-10 | 8 | 206 | 5 | 1690992 | ||
| Pubmed | DAB2IP CDK12 BIRC6 ZNF608 AMOT DOP1B AKAP6 DMXL2 VPS39 ARHGEF10 HELZ2 DNM3 WDFY3 | 1.07e-09 | 225 | 206 | 13 | 12168954 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | CORO1C BIRC6 HNRNPK NCAPG GANAB GRK2 NOMO2 PLEC DNM2 CPS1 NOMO1 MTM1 HELZ2 NOMO3 TP53BP1 | 2.64e-09 | 344 | 206 | 15 | 30333137 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | TRIO DOCK5 AHNAK XRN1 UTP20 PLEC HERC2 DNMT1 DNAJC13 SALL4 MTOR LTN1 | 3.49e-09 | 202 | 206 | 12 | 33005030 |
| Pubmed | DAB2IP AGO2 UBAP2 TRIO CORO1C PTK2 HNRNPK HERC2 NIPBL RAC1 DNM2 DNMT1 DMXL2 DNAJC13 SPATA20 GRIN2A TBL1XR1 MTOR CSNK2A1 DNM3 WDFY3 TP53BP1 TP53BP2 | 1.70e-08 | 963 | 206 | 23 | 28671696 | |
| Pubmed | 2.88e-08 | 16 | 206 | 5 | 23123061 | ||
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 4.13e-08 | 7 | 206 | 4 | 7794280 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | UBAP2 TRIO DDX6 PTPN13 PIK3C3 CEP95 AMOT AHNAK XRN1 NHS PLEC SIPA1L2 DNMT1 CCDC102A DOP1B PARD3B CBX4 DENND4C ARHGEF10 MTOR TP53BP2 | 5.22e-08 | 861 | 206 | 21 | 36931259 |
| Pubmed | DAB2IP AGO2 TRIO CORO1C BIRC6 NCAPG PTPN13 GANAB AHNAK NHS HERC2 DNMT1 KPNA2 KPNA3 KPNA4 DNAJC13 PDPR POSTN PRPF3 CSNK2A1 MTM1 LTN1 TP53BP2 | 8.01e-08 | 1049 | 206 | 23 | 27880917 | |
| Pubmed | DAB2IP SLC7A13 STAT1 HNRNPK STAT6 SIAE INTS14 PTPN13 AMOT TMEM131L PLEC DNM2 KPNA3 AKAP6 VPS39 SALL4 APOB DEPDC1 INO80 PRAMEF8 LTN1 ESPL1 TP53BP1 | 1.43e-07 | 1084 | 206 | 23 | 11544199 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP TRIO CDK12 TMC6 SREBF1 ZNF236 BIRC6 RYR1 AHNAK PLEC HERC2 SIPA1L2 ZNF687 MVB12B VPS39 SPATA20 INO80 RALGAPA2 LLGL2 MTOR HELZ2 WDFY3 ESPL1 | 2.01e-07 | 1105 | 206 | 23 | 35748872 |
| Pubmed | Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. | 2.05e-07 | 3 | 206 | 3 | 21474067 | |
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 36011023 | ||
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 18394438 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.05e-07 | 3 | 206 | 3 | 25576386 | |
| Pubmed | AGO2 UBAP2 CDK12 CORO1C STAT1 HNRNPK NCAPG PTPN13 AMOT AHNAK XRN1 WDR44 DNMT1 KPNA2 TP53BP1 TP53BP2 | 2.11e-07 | 549 | 206 | 16 | 38280479 | |
| Pubmed | 2.44e-07 | 10 | 206 | 4 | 20235787 | ||
| Pubmed | 2.44e-07 | 10 | 206 | 4 | 35021089 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | AGO2 UBAP2 PTK2 HNRNPK DDX6 PTPN13 GRK2 AMOT AHNAK XRN1 PLEC EEFSEC DNAJC13 TUT4 INO80 CHMP4B USP16 ESPL1 | 3.72e-07 | 724 | 206 | 18 | 36232890 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AGO2 CORO1C BIRC6 PTK2 STAT1 HNRNPK DDX6 NCAPG AHNAK XRN1 UTP20 PLEC HERC2 MVP NIPBL DNMT1 KPNA3 DNAJC13 USP16 SMC3 PRPF3 LTN1 WDFY3 TP53BP1 TP53BP2 | 5.27e-07 | 1353 | 206 | 25 | 29467282 |
| Pubmed | 5.82e-07 | 162 | 206 | 9 | 25826454 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MDH1 RYR1 SIAE PTPN13 GANAB MVB12A AHNAK UGP2 MVP NIPBL DNM2 DOP1B MVB12B NPHS1 DNAJC13 MXRA5 TUT4 ABCC11 CHMP4B PTGR1 FUCA1 | 7.88e-07 | 1016 | 206 | 21 | 19056867 |
| Pubmed | CDK12 GANAB SIPA1L2 KPNA2 PDPR SALL4 INO80 CHMP4B SMC3 PRPF3 CSNK2A1 HASPIN TP53BP1 | 8.06e-07 | 396 | 206 | 13 | 26687479 | |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 18021343 | ||
| Pubmed | Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients. | 8.16e-07 | 4 | 206 | 3 | 17922881 | |
| Pubmed | The circular RNA circBIRC6 participates in the molecular circuitry controlling human pluripotency. | 8.16e-07 | 4 | 206 | 3 | 29074849 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 8.16e-07 | 4 | 206 | 3 | 31833031 | |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 19337788 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 25957634 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 9267806 | ||
| Pubmed | MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection. | 8.16e-07 | 4 | 206 | 3 | 29370303 | |
| Pubmed | Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians. | 8.16e-07 | 4 | 206 | 3 | 24443221 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 8.20e-07 | 13 | 206 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 8.20e-07 | 13 | 206 | 4 | 19273835 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 20044046 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 32150576 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 8.20e-07 | 13 | 206 | 4 | 12832451 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 25406283 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 8380065 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 1279194 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 25724769 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 8.20e-07 | 13 | 206 | 4 | 22092845 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 8.20e-07 | 13 | 206 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 8.20e-07 | 13 | 206 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 8.20e-07 | 13 | 206 | 4 | 23800882 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 8.20e-07 | 13 | 206 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 8.20e-07 | 13 | 206 | 4 | 39168268 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 8402684 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 8.20e-07 | 13 | 206 | 4 | 21949477 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 26219866 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 2133556 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 8.20e-07 | 13 | 206 | 4 | 19358828 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 8.20e-07 | 13 | 206 | 4 | 34058224 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 8.20e-07 | 13 | 206 | 4 | 23935487 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 34950606 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 8.20e-07 | 13 | 206 | 4 | 25972571 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 8.20e-07 | 13 | 206 | 4 | 15220458 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 18843289 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 15207636 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 21081647 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 11133662 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 11483763 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 18003729 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 8.20e-07 | 13 | 206 | 4 | 27695943 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 8.20e-07 | 13 | 206 | 4 | 16638824 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 8.20e-07 | 13 | 206 | 4 | 21670291 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 22162753 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 2702644 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 11801635 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 21760897 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 1719235 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 16619040 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 8.20e-07 | 13 | 206 | 4 | 8209741 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 32521208 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 8.20e-07 | 13 | 206 | 4 | 29967450 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 1653760 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 32169849 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 8.20e-07 | 13 | 206 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 8.20e-07 | 13 | 206 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 8.20e-07 | 13 | 206 | 4 | 15316023 | |
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 15331748 | ||
| Pubmed | 8.20e-07 | 13 | 206 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 8.20e-07 | 13 | 206 | 4 | 22406619 | |
| Interaction | HDAC1 interactions | SREBF1 JDP2 BIRC6 STAT1 NCAPG PTPN13 GANAB ZNF608 BRCA2 NFATC2 AMOT AHNAK XRN1 PLEC ZNF687 DNMT1 KPNA2 KPNA3 KPNA4 DNAJC13 GPAM SALL4 E2F4 TBL1XR1 DENND4C PPP2R1B SMC3 CSNK2A1 CSNK2A3 TP53BP2 | 7.48e-07 | 1108 | 203 | 30 | int:HDAC1 |
| Interaction | LRRC31 interactions | TRIO DOCK5 AHNAK XRN1 UTP20 PLEC HERC2 DNMT1 DNAJC13 SALL4 MTOR LTN1 | 1.20e-06 | 205 | 203 | 12 | int:LRRC31 |
| Interaction | HDAC2 interactions | TRIO JDP2 HNRNPK KRT80 NCAPG GANAB BRCA2 AHNAK UTP20 HERC2 ZNF687 DNMT1 KPNA2 KPNA3 KPNA4 DNAJC13 SALL4 CPS1 TBL1XR1 DENND4C SMC3 CSNK2A1 HELZ2 ESPL1 CSNK2A3 | 2.19e-06 | 865 | 203 | 25 | int:HDAC2 |
| Interaction | RCOR1 interactions | BIRC6 NCAPG PTPN13 BRCA2 NFATC2 AMOT AHNAK XRN1 PLEC ZNF687 KPNA2 DNAJC13 TBL1XR1 DENND4C LLGL2 CSNK2A1 TP53BP1 TP53BP2 | 2.83e-06 | 494 | 203 | 18 | int:RCOR1 |
| Interaction | PLA2G12B interactions | 9.92e-06 | 5 | 203 | 3 | int:PLA2G12B | |
| Interaction | DUSP2 interactions | 1.76e-05 | 81 | 203 | 7 | int:DUSP2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 9.97e-09 | 11 | 136 | 5 | 1315 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.68e-04 | 3 | 136 | 2 | 287 | |
| GeneFamily | Armadillo repeat containing|Importins | 3.13e-04 | 18 | 136 | 3 | 596 | |
| GeneFamily | Glycerol-3-phosphate acyltransferases | 3.34e-04 | 4 | 136 | 2 | 1035 | |
| GeneFamily | Ferlin family | 8.26e-04 | 6 | 136 | 2 | 828 | |
| GeneFamily | PDZ domain containing | 1.02e-03 | 152 | 136 | 6 | 1220 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.15e-03 | 7 | 136 | 2 | 1201 | |
| GeneFamily | Fibronectin type III domain containing | 1.33e-03 | 160 | 136 | 6 | 555 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.47e-03 | 163 | 136 | 6 | 590 | |
| GeneFamily | Cytochrome P450 family 3 | 1.53e-03 | 8 | 136 | 2 | 1002 | |
| GeneFamily | ESCRT-I | 1.95e-03 | 9 | 136 | 2 | 1116 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.12e-03 | 43 | 136 | 3 | 409 | |
| GeneFamily | Integrator complex | 5.53e-03 | 15 | 136 | 2 | 1366 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | AGO2 TRIO PTK2 MALT1 PTPN13 BRCA2 PIK3C3 TMEM131L UTP20 FLRT2 NIPBL DOP1B KPNA3 DMXL2 DNAJC13 TUT4 SMC3 ARHGEF10 CSNK2A1 LTN1 RPGR WDFY3 TP53BP1 TP53BP2 | 7.77e-08 | 856 | 206 | 24 | M4500 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 2.94e-07 | 35 | 206 | 6 | MM757 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP | 1.07e-05 | 175 | 206 | 9 | M6690 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 184 | 205 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.57e-06 | 187 | 205 | 8 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-06 | 188 | 205 | 8 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.27e-06 | 136 | 205 | 7 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-06 | 194 | 205 | 8 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-06 | 194 | 205 | 8 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-06 | 199 | 205 | 8 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.07e-06 | 199 | 205 | 8 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.77e-06 | 144 | 205 | 7 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-05 | 162 | 205 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 110 | 205 | 6 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-05 | 166 | 205 | 7 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-05 | 173 | 205 | 7 | d17e50dc400098374af626803dec1241ec566769 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 175 | 205 | 7 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | Ciliated_cells-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.97e-05 | 179 | 205 | 7 | 1c41314b6fcfcac8d62034e7037570120d58f20f | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Calb2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.18e-05 | 73 | 205 | 5 | 8e8d06bd4404fe6fda753e7adedc2f2150524750 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Calb2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.18e-05 | 73 | 205 | 5 | 48a499fa03d736310d09b01c8889db5288e9b2da | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.43e-05 | 185 | 205 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.43e-05 | 185 | 205 | 7 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 186 | 205 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 186 | 205 | 7 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 186 | 205 | 7 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.52e-05 | 186 | 205 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-05 | 187 | 205 | 7 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-05 | 187 | 205 | 7 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-05 | 187 | 205 | 7 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 187 | 205 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 189 | 205 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.79e-05 | 189 | 205 | 7 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 190 | 205 | 7 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.89e-05 | 190 | 205 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-05 | 191 | 205 | 7 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.19e-05 | 193 | 205 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-05 | 194 | 205 | 7 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | 15-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 3.52e-05 | 196 | 205 | 7 | 0e45817625b96d21a8cc4dfbbd465ee6403b6802 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.52e-05 | 196 | 205 | 7 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 196 | 205 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-05 | 196 | 205 | 7 | eb8c9a4a5eb21d43ff7b25deae5896c236f669b9 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 197 | 205 | 7 | 4edf043e8f586fd375f56485841fe992a18bf853 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-05 | 197 | 205 | 7 | ea9332adf753d7e92f89654320543abb9e6142aa | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.64e-05 | 197 | 205 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-T_reticular|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-05 | 198 | 205 | 7 | 11f21a4a97da10fc6ae604cb627aa3af749d9dff | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.75e-05 | 198 | 205 | 7 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.75e-05 | 198 | 205 | 7 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.75e-05 | 198 | 205 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.75e-05 | 198 | 205 | 7 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-05 | 198 | 205 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.88e-05 | 199 | 205 | 7 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.88e-05 | 199 | 205 | 7 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.88e-05 | 199 | 205 | 7 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.00e-05 | 200 | 205 | 7 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.00e-05 | 200 | 205 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.00e-05 | 200 | 205 | 7 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.00e-05 | 200 | 205 | 7 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.00e-05 | 200 | 205 | 7 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.00e-05 | 200 | 205 | 7 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 145 | 205 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.15e-05 | 151 | 205 | 6 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.42e-05 | 152 | 205 | 6 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.27e-05 | 155 | 205 | 6 | 583cfaa41c755c63aee312eb442e9d97f645d5f7 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 8.56e-05 | 156 | 205 | 6 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 159 | 205 | 6 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 160 | 205 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 160 | 205 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 161 | 205 | 6 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.09e-04 | 163 | 205 | 6 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 165 | 205 | 6 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 167 | 205 | 6 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 167 | 205 | 6 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.24e-04 | 167 | 205 | 6 | 013971700e80b71e4b8c79b8fff0d8beeac295c3 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 167 | 205 | 6 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-STAT1+_Naive_B|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 168 | 205 | 6 | ba127d97697202a8558a0d50bcdafa30b0509de1 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 1.29e-04 | 168 | 205 | 6 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 169 | 205 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 169 | 205 | 6 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 169 | 205 | 6 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 169 | 205 | 6 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-04 | 170 | 205 | 6 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.42e-04 | 171 | 205 | 6 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 172 | 205 | 6 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 172 | 205 | 6 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.46e-04 | 172 | 205 | 6 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 173 | 205 | 6 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-04 | 173 | 205 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-04 | 173 | 205 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 174 | 205 | 6 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 174 | 205 | 6 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.56e-04 | 174 | 205 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 174 | 205 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 175 | 205 | 6 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 175 | 205 | 6 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 175 | 205 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.66e-04 | 176 | 205 | 6 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-04 | 176 | 205 | 6 | 75412d58438d71c49a6096bb2ef12b7f349653d8 | |
| Drug | Hexobarbital | 7.19e-07 | 3 | 205 | 3 | ctd:D006591 | |
| Drug | flubendiamide | 7.19e-07 | 3 | 205 | 3 | CID011193251 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | KIAA0586 PTK2 BRCA2 DOP1B MVB12B KPNA4 CHST10 PPP2R1B INTS9 ESPL1 TP53BP2 | 1.10e-06 | 187 | 205 | 11 | 4989_DN |
| Drug | chlorpyrifos oxon | 1.74e-06 | 64 | 205 | 7 | CID000021804 | |
| Drug | hydroxytrimipramine | 2.86e-06 | 4 | 205 | 3 | CID000160610 | |
| Drug | N-ethyl-3-toluamide | 2.86e-06 | 4 | 205 | 3 | ctd:C454678 | |
| Drug | M3/M4 | 9.31e-06 | 32 | 205 | 5 | CID000486507 | |
| Drug | orphenadrine | 1.11e-05 | 56 | 205 | 6 | CID000004601 | |
| Drug | dmDBP | 1.41e-05 | 6 | 205 | 3 | CID005316801 | |
| Drug | Cyproterone Acetate | 1.47e-05 | 35 | 205 | 5 | ctd:D017373 | |
| Drug | hydroxytolbutamide | 2.23e-05 | 19 | 205 | 4 | CID000003656 | |
| Drug | chloral hydrate | 2.26e-05 | 129 | 205 | 8 | CID000002707 | |
| Drug | zoledronic acid | PSG4 CYP3A5 PDK4 ERGIC2 BIRC6 PTK2 STAT1 KRT80 MALT1 NCAPG PTPN13 BPGM BRCA2 NHS PLEC MVP MOCS1 RAC1 ABI3BP ADAMTS1 C6orf89 SCG5 DEPDC1 CHMP4B TBL1XR1 RGS14 LLGL2 FUCA1 MVK CACNA2D3 | 2.30e-05 | 1472 | 205 | 30 | ctd:C088658 |
| Drug | desmethyltrimipramine | 2.45e-05 | 7 | 205 | 3 | CID000160632 | |
| Drug | 16-O-demethylaconitine | 2.45e-05 | 7 | 205 | 3 | ctd:C486136 | |
| Drug | Voriconazole | 2.45e-05 | 7 | 205 | 3 | ctd:D065819 | |
| Drug | 5-hydroxydiclofenac | 2.45e-05 | 7 | 205 | 3 | ctd:C117715 | |
| Drug | ginsenoside Rc | 2.76e-05 | 20 | 205 | 4 | CID000100018 | |
| Drug | AC1L1UOE | 3.24e-05 | 41 | 205 | 5 | CID000010191 | |
| Drug | Flunitrazepam | 3.39e-05 | 21 | 205 | 4 | ctd:D005445 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 3.90e-05 | 8 | 205 | 3 | CID006439499 | |
| Drug | 11-HODE | 3.90e-05 | 8 | 205 | 3 | CID006438497 | |
| Drug | 4-hydroxyalprazolam | 3.90e-05 | 8 | 205 | 3 | CID000182017 | |
| Drug | Hcda | 3.90e-05 | 8 | 205 | 3 | CID005312573 | |
| Drug | AC1L1IPV | 4.11e-05 | 43 | 205 | 5 | CID000004683 | |
| Drug | 3-methylcholanthrene | CYP2C19 CYP3A4 CYP3A5 SREBF1 PTK2 SIAE UGP2 PLEC ADAMTS1 APOB | 4.91e-05 | 231 | 205 | 10 | CID000001674 |
| Drug | pentanol | 4.94e-05 | 23 | 205 | 4 | CID000006276 | |
| Drug | nimodipine | 5.23e-05 | 145 | 205 | 8 | CID000004497 | |
| Drug | nicardipine | 5.23e-05 | 145 | 205 | 8 | CID000004473 | |
| Drug | ethosuximide | 5.51e-05 | 74 | 205 | 6 | CID000003291 | |
| Drug | stilbene oxide | 5.51e-05 | 74 | 205 | 6 | CID000028649 | |
| Drug | PD138142-15 | 5.81e-05 | 9 | 205 | 3 | CID003025787 | |
| Drug | pentol | 5.81e-05 | 9 | 205 | 3 | CID006436590 | |
| Drug | phenylcyclopropane | 5.81e-05 | 9 | 205 | 3 | CID000070112 | |
| Drug | Tat11 | 5.81e-05 | 9 | 205 | 3 | CID000480142 | |
| Drug | AC1L44DC | 6.96e-05 | 25 | 205 | 4 | CID000150456 | |
| Drug | Midazolam | 6.96e-05 | 25 | 205 | 4 | ctd:D008874 | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 7.77e-05 | 197 | 205 | 9 | 6229_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; HL60; HT_HG-U133A | 7.77e-05 | 197 | 205 | 9 | 2544_DN | |
| Drug | 4-hydroxymidazolam | 8.07e-05 | 2 | 205 | 2 | ctd:C042940 | |
| Drug | 1,3,8-trihydroxy-6-hydroxymethylanthraquinone | 8.07e-05 | 2 | 205 | 2 | ctd:C053854 | |
| Drug | estradiol-17 beta-3-methyl ether | 8.07e-05 | 2 | 205 | 2 | ctd:C025004 | |
| Drug | norverapamil | 8.07e-05 | 2 | 205 | 2 | ctd:C016904 | |
| Drug | 5,6-dihydro-2H-pyran-2-one | 8.07e-05 | 2 | 205 | 2 | CID000520660 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 8.07e-05 | 2 | 205 | 2 | ctd:C005147 | |
| Drug | notopterol | 8.07e-05 | 2 | 205 | 2 | CID005320227 | |
| Drug | N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide | 8.07e-05 | 2 | 205 | 2 | ctd:C114289 | |
| Drug | 2,2,2-trifluoroethyl allyl ether | 8.07e-05 | 2 | 205 | 2 | CID000015208 | |
| Drug | asiaticoside | 8.07e-05 | 2 | 205 | 2 | ctd:C004446 | |
| Drug | fluroxene | 8.07e-05 | 2 | 205 | 2 | CID000009844 | |
| Drug | madecassoside | 8.07e-05 | 2 | 205 | 2 | ctd:C093443 | |
| Drug | 6 beta-hydroxytestosterone | 8.07e-05 | 2 | 205 | 2 | ctd:C025591 | |
| Drug | 5-BMF | 8.07e-05 | 2 | 205 | 2 | CID000132858 | |
| Drug | CQA 206-291 | 8.07e-05 | 2 | 205 | 2 | ctd:C059483 | |
| Drug | fructus schizandrae, radix ginseng, radix ophiopogonis drug combination | 8.07e-05 | 2 | 205 | 2 | ctd:C009252 | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; HL60; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 2188_DN | |
| Drug | MEGX | 8.17e-05 | 26 | 205 | 4 | CID000024415 | |
| Drug | Celsior | 8.24e-05 | 10 | 205 | 3 | ctd:C088453 | |
| Drug | 8-hydroxydaidzein | 8.24e-05 | 10 | 205 | 3 | CID005466139 | |
| Drug | 4-hydroxymidazolam | 8.24e-05 | 10 | 205 | 3 | CID000124449 | |
| Drug | hypaconitine | 8.24e-05 | 10 | 205 | 3 | ctd:C058309 | |
| Drug | 3 PL | 8.24e-05 | 10 | 205 | 3 | CID000007707 | |
| Drug | AHMA | 8.24e-05 | 10 | 205 | 3 | CID000216240 | |
| Drug | 4-hydroxydebrisoquine | 8.24e-05 | 10 | 205 | 3 | CID000107669 | |
| Drug | WY-14643; Down 200; 100uM; SKMEL5; HG-U133A | 8.40e-05 | 199 | 205 | 9 | 495_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HG-U133A | 8.40e-05 | 199 | 205 | 9 | 484_DN | |
| Drug | Leflunomide [75706-12-6]; Down 200; 14.8uM; HL60; HT_HG-U133A | TRIO CHRNA5 FLRT2 DMXL2 ADAMTS1 RGS14 ARHGEF10 XPNPEP3 WDFY3 | 8.40e-05 | 199 | 205 | 9 | 2539_DN |
| Drug | lamotrigine | 8.81e-05 | 116 | 205 | 7 | CID000003878 | |
| Drug | bupropion | 9.17e-05 | 81 | 205 | 6 | CID000000444 | |
| Drug | nifedipine | CYP2C19 CYP3A4 CYP3A5 BIRC6 RYR1 RYR3 CYP2W1 GRK2 GRIN2A GRIN2C BCO2 LUM CACNA2D3 | 1.06e-04 | 415 | 205 | 13 | CID000004485 |
| Drug | Haloperidol metabolite I | 1.13e-04 | 11 | 205 | 3 | CID000038282 | |
| Drug | PCB 66 | 1.13e-04 | 11 | 205 | 3 | CID000036185 | |
| Drug | clozapine N-oxide | 1.13e-04 | 11 | 205 | 3 | ctd:C079149 | |
| Drug | Ticalopride | 1.13e-04 | 11 | 205 | 3 | CID000216236 | |
| Drug | triazolam | 1.25e-04 | 54 | 205 | 5 | CID000005556 | |
| Drug | 3-isothujone | 1.46e-04 | 30 | 205 | 4 | CID000011027 | |
| Drug | 5-hydroxydiclofenac | 1.49e-04 | 12 | 205 | 3 | CID003052566 | |
| Drug | 2-Tbmbfd | 1.49e-04 | 12 | 205 | 3 | CID000126928 | |
| Drug | 4-(N-propionylanilino)piperidine | 1.49e-04 | 12 | 205 | 3 | CID000259381 | |
| Drug | norclozapine | 1.49e-04 | 12 | 205 | 3 | ctd:C058272 | |
| Drug | gabapentin | 1.52e-04 | 169 | 205 | 8 | CID000003446 | |
| Drug | 7-methoxycoumarin | 1.61e-04 | 57 | 205 | 5 | CID000010748 | |
| Drug | Chlorpyrifos | CYP2C19 CYP3A4 CYP3A5 CDK12 BIRC6 CHRNA5 PTK2 HNRNPK CHRNE ARL5C SIAE NCAPG GRK2 FKTN AMOT ABI3BP SPATA20 CBX4 GRIN2A TBL1XR1 HYDIN | 1.65e-04 | 960 | 205 | 21 | ctd:D004390 |
| Drug | caffeine | CYP2C19 CYP3A4 CYP3A5 RYR1 RYR3 CHRNE CYP2W1 GRK2 XRN1 AKAP6 GRIN2A GRIN2C INO80 LTN1 CACNA2D3 | 1.86e-04 | 562 | 205 | 15 | CID000002519 |
| Drug | NSC-673323 | 1.88e-04 | 32 | 205 | 4 | CID000384101 | |
| Drug | flunitrazepam | 1.90e-04 | 59 | 205 | 5 | CID000003380 | |
| Drug | THDCA | 1.92e-04 | 13 | 205 | 3 | CID000119046 | |
| Drug | AC1L18GM | 1.92e-04 | 13 | 205 | 3 | CID000000092 | |
| Drug | AC1Q3V55 | 1.92e-04 | 13 | 205 | 3 | CID000115317 | |
| Drug | 1'-hydroxymidazolam | 1.92e-04 | 13 | 205 | 3 | CID000107917 | |
| Drug | clozapine N-oxide | 1.92e-04 | 13 | 205 | 3 | CID000036727 | |
| Drug | 5-hydroxyomeprazole | 1.92e-04 | 13 | 205 | 3 | CID000119560 | |
| Drug | Glucose | CCPG1 CYP2C19 ERN1 CYP3A4 PDK4 SREBF1 MDH1 NDRG2 PTK2 STAT1 HNRNPK SIAE AMOT FLRT2 MVP NIPBL RAC1 NOBOX KPNA3 DMXL2 ADAMTS1 APOB USP16 MTOR MTM1 XPNPEP3 TP53BP1 | 1.93e-04 | 1420 | 205 | 27 | ctd:D005947 |
| Drug | methadone | 2.06e-04 | 60 | 205 | 5 | CID000004095 | |
| Drug | nilvadipine | 2.06e-04 | 60 | 205 | 5 | CID000004494 | |
| Drug | Polychlorinated Biphenyls | GABRG2 CYP3A4 PSG7 MDH1 KRT80 DDX6 MALT1 NCAPG XRN1 TMEM131L FLRT2 DNMT1 KPNA2 ARHGEF10 MTOR LUM | 2.10e-04 | 633 | 205 | 16 | ctd:D011078 |
| Drug | Thimerosal | TMC6 ERGIC2 STK35 PTK2 RYR3 DDX6 INTS14 MVB12A BRCA2 NIPBL DNAJC13 IGDCC3 PARD3B SALL4 CPS1 RALGAPA2 TBL1XR1 USP16 ARHGEF10 FER1L4 LTN1 LGR6 WDFY3 TP53BP1 | 2.13e-04 | 1199 | 205 | 24 | ctd:D013849 |
| Drug | Proresid | 2.17e-04 | 134 | 205 | 7 | CID000015184 | |
| Drug | 1,3-di-o-tolylguanidine | 2.23e-04 | 61 | 205 | 5 | CID000007333 | |
| Drug | NSC281245 | 2.34e-04 | 96 | 205 | 6 | CID000002854 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.18e-06 | 28 | 200 | 5 | DOID:3717 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 3.42e-06 | 93 | 200 | 7 | C1535926 | |
| Disease | cD177 antigen measurement | 5.82e-06 | 18 | 200 | 4 | EFO_0021866 | |
| Disease | Malignant neoplasm of breast | CYP3A4 STAT1 HNRNPK BRCA2 FKTN NHS UTP20 HERC2 DNAH9 NIPBL RAC2 DNMT1 AKAP6 ADAMTS1 VPS39 HELQ LLGL2 MTOR LGR6 TP53BP1 TP53BP2 | 1.44e-05 | 1074 | 200 | 21 | C0006142 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.04e-05 | 49 | 200 | 5 | DOID:0060037 (implicated_via_orthology) | |
| Disease | lung large cell carcinoma (is_marker_for) | 4.57e-05 | 2 | 200 | 2 | DOID:4556 (is_marker_for) | |
| Disease | Proton pump inhibitor response | 4.57e-05 | 2 | 200 | 2 | cv:CN297082 | |
| Disease | Esomeprazole response | 4.57e-05 | 2 | 200 | 2 | cv:CN077982 | |
| Disease | Liver carcinoma | PDK4 SREBF1 JDP2 PTK2 STAT1 NCAPG RAC1 ADAMTS1 DEPDC1 BCO2 MTOR MTBP MVK | 4.68e-05 | 507 | 200 | 13 | C2239176 |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 5.06e-05 | 59 | 200 | 5 | EFO_0001663, MONDO_0005148 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 8.34e-05 | 13 | 200 | 3 | C3661489 | |
| Disease | Centronuclear myopathy | 8.34e-05 | 13 | 200 | 3 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 8.34e-05 | 13 | 200 | 3 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 8.34e-05 | 13 | 200 | 3 | C4551952 | |
| Disease | Congenital Structural Myopathy | 8.34e-05 | 13 | 200 | 3 | C0752282 | |
| Disease | Kartagener Syndrome | 9.10e-05 | 35 | 200 | 4 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 9.10e-05 | 35 | 200 | 4 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 9.10e-05 | 35 | 200 | 4 | C4317124 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 1.06e-04 | 14 | 200 | 3 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 1.06e-04 | 14 | 200 | 3 | C0410207 | |
| Disease | epilepsy (implicated_via_orthology) | 1.29e-04 | 163 | 200 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.31e-04 | 15 | 200 | 3 | C3645536 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.37e-04 | 3 | 200 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.37e-04 | 3 | 200 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder 48 (implicated_via_orthology) | 1.37e-04 | 3 | 200 | 2 | DOID:0080235 (implicated_via_orthology) | |
| Disease | Epilepsy, Rolandic | 1.37e-04 | 3 | 200 | 2 | C0376532 | |
| Disease | Benign Rolandic Epilepsy | 1.37e-04 | 3 | 200 | 2 | C2363129 | |
| Disease | Congenital Fiber Type Disproportion | 2.32e-04 | 18 | 200 | 3 | C0546264 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 2.72e-04 | 4 | 200 | 2 | EFO_0801909 | |
| Disease | Centronuclear myopathy | 2.72e-04 | 4 | 200 | 2 | cv:C0175709 | |
| Disease | age-related macular degeneration, cataract, glaucoma | 2.72e-04 | 4 | 200 | 2 | EFO_0001365, MONDO_0005041, MONDO_0005129 | |
| Disease | tacrolimus measurement | 2.72e-04 | 4 | 200 | 2 | EFO_0008458 | |
| Disease | Clozapine response | 2.72e-04 | 4 | 200 | 2 | cv:CN077971 | |
| Disease | response to hydrochlorothiazide, triglyceride measurement | 2.91e-04 | 47 | 200 | 4 | EFO_0004530, EFO_0005202 | |
| Disease | Primary Ciliary Dyskinesia | 2.91e-04 | 47 | 200 | 4 | C4551720 | |
| Disease | Breast Carcinoma | CYP3A4 HNRNPK BRCA2 HERC2 DNMT1 ADAMTS1 VPS39 LLGL2 MTOR LGR6 TP53BP1 TP53BP2 | 3.30e-04 | 538 | 200 | 12 | C0678222 |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 4.51e-04 | 5 | 200 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 4.51e-04 | 5 | 200 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 4.51e-04 | 5 | 200 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 4.51e-04 | 5 | 200 | 2 | C1853099 | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 4.51e-04 | 5 | 200 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | Cornelia de Lange Syndrome 1 | 4.51e-04 | 5 | 200 | 2 | C4551851 | |
| Disease | creatinine measurement | SLC7A13 CDK12 TMC6 BIRC6 RYR1 TMEM131L PLEC KPNA3 NPHS1 EEFSEC DNAJC13 SPATA20 INO80 CPS1 RGS14 SLC22A3 AGMAT | 4.69e-04 | 995 | 200 | 17 | EFO_0004518 |
| Disease | Carcinoma of lung | 4.92e-04 | 23 | 200 | 3 | C0684249 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 5.59e-04 | 24 | 200 | 3 | DOID:1184 (biomarker_via_orthology) | |
| Disease | mental development measurement | 6.32e-04 | 25 | 200 | 3 | EFO_0008230 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0801907 | |
| Disease | De Lange syndrome | 6.74e-04 | 6 | 200 | 2 | cv:C0270972 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 6.74e-04 | 6 | 200 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 7.11e-04 | 26 | 200 | 3 | DOID:234 (is_implicated_in) | |
| Disease | intraocular pressure measurement | CHRNE FAM186A HERC2 MVB12B MXRA5 C6orf89 PCDHGA5 PARD3B KLHL38 MTOR LUM | 7.55e-04 | 509 | 200 | 11 | EFO_0004695 |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0801906 | |
| Disease | Seizure, Febrile, Simple | 9.39e-04 | 7 | 200 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 9.39e-04 | 7 | 200 | 2 | C0751057 | |
| Disease | centronuclear myopathy (implicated_via_orthology) | 9.39e-04 | 7 | 200 | 2 | DOID:14717 (implicated_via_orthology) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 9.39e-04 | 7 | 200 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | CYP3A4 HNRNPK BRCA2 DNMT1 ADAMTS1 VPS39 LLGL2 MTOR LGR6 TP53BP1 TP53BP2 | 9.71e-04 | 525 | 200 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | CYP3A4 HNRNPK BRCA2 DNMT1 ADAMTS1 VPS39 LLGL2 MTOR LGR6 TP53BP1 TP53BP2 | 9.71e-04 | 525 | 200 | 11 | C1257931 |
| Disease | Mammary Neoplasms | CYP3A4 HNRNPK BRCA2 DNMT1 ADAMTS1 VPS39 LLGL2 MTOR LGR6 TP53BP1 TP53BP2 | 1.00e-03 | 527 | 200 | 11 | C1458155 |
| Disease | lymphocyte count | CYP2C19 UBAP2 CYP3A4 CYP3A5 SREBF1 JDP2 HNRNPK BPGM ZMYND10 NFATC2 AHNAK DMBT1 PLEC RAC2 DNMT1 KPNA3 LETM2 ZAN PCDHGA5 PCDHGA4 CPS1 | 1.01e-03 | 1464 | 200 | 21 | EFO_0004587 |
| Disease | forced expiratory volume | CYP3A4 CDK12 CHRNA5 CEP95 AHNAK KPNA3 EEFSEC PCDHGA5 PARD3B GRIN2A INO80 LLGL2 DNM3 CACNA2D3 | 1.04e-03 | 789 | 200 | 14 | EFO_0004314 |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.12e-03 | 67 | 200 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | Polydactyly | 1.23e-03 | 117 | 200 | 5 | C0152427 | |
| Disease | lymphatic vessel endothelial hyaluronic acid receptor 1 measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0020539 | |
| Disease | Cornelia De Lange Syndrome | 1.25e-03 | 8 | 200 | 2 | C0270972 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.28e-03 | 239 | 200 | 7 | EFO_0010934 | |
| Disease | keratinocyte carcinoma | 1.28e-03 | 118 | 200 | 5 | EFO_0010176 | |
| Disease | urinary metabolite measurement | 1.47e-03 | 245 | 200 | 7 | EFO_0005116 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.51e-03 | 181 | 200 | 6 | DOID:684 (is_implicated_in) | |
| Disease | body surface area | DDX6 DOCK5 BPGM ZNF608 PLEC DNMT1 LINGO2 CPS1 MTOR DNM3 LUM MVK | 1.55e-03 | 643 | 200 | 12 | EFO_0022196 |
| Disease | coffee consumption measurement | 1.56e-03 | 182 | 200 | 6 | EFO_0006781 | |
| Disease | alkaline phosphatase measurement | ERN1 ERGIC2 DDX6 CHRNE CYP2W1 AHNAK DMBT1 DNMT1 DNAJC13 GPAM APOB CPS1 RHPN2 SCUBE3 TP53BP1 TCTN2 | 1.59e-03 | 1015 | 200 | 16 | EFO_0004533 |
| Disease | Febrile Convulsions | 1.59e-03 | 9 | 200 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.59e-03 | 9 | 200 | 2 | C3502809 | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 1.86e-03 | 36 | 200 | 3 | DOID:3907 (is_marker_for) | |
| Disease | Cardiovascular Diseases | 1.86e-03 | 36 | 200 | 3 | C0007222 | |
| Disease | response to serotonin-norephinephrine reuptake inhibitor | 1.86e-03 | 36 | 200 | 3 | EFO_0006325 | |
| Disease | basal cell carcinoma | 1.89e-03 | 189 | 200 | 6 | EFO_0004193 | |
| Disease | platelet glycoprotein ib alpha chain measurement | 1.98e-03 | 10 | 200 | 2 | EFO_0020645 | |
| Disease | apolipoprotein B measurement | PTK2 NCAPG BRCA2 SORCS2 PLEC DNM2 DNAJC13 APOB FER1L4 SLC22A3 XPNPEP3 HYDIN | 2.00e-03 | 663 | 200 | 12 | EFO_0004615 |
| Disease | cholesterol in large HDL measurement | 2.17e-03 | 80 | 200 | 4 | EFO_0021900 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.21e-03 | 195 | 200 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Abnormality of refraction | CDK12 ABHD6 STK35 BIRC6 BOD1 ZNF608 MVB12B KPNA2 AKAP6 DNAJC13 GRIN2A FER1L4 | 2.26e-03 | 673 | 200 | 12 | HP_0000539 |
| Disease | non-melanoma skin carcinoma | 2.29e-03 | 265 | 200 | 7 | EFO_0009260 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.32e-03 | 197 | 200 | 6 | EFO_0005680 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 2.34e-03 | 39 | 200 | 3 | EFO_0022332 | |
| Disease | endometrial neoplasm | 2.42e-03 | 11 | 200 | 2 | EFO_0004230 | |
| Disease | smoking status measurement, forced expiratory volume | 2.42e-03 | 11 | 200 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | cancer (implicated_via_orthology) | 2.44e-03 | 268 | 200 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.52e-03 | 40 | 200 | 3 | EFO_0004746 | |
| Disease | kidney disease (implicated_via_orthology) | 2.71e-03 | 41 | 200 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | cataract | 2.80e-03 | 141 | 200 | 5 | MONDO_0005129 | |
| Disease | cesarean section, intelligence | 2.89e-03 | 12 | 200 | 2 | EFO_0004337, EFO_0009636 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.89e-03 | 12 | 200 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | methionine sulfone measurement | 2.89e-03 | 12 | 200 | 2 | EFO_0800072 | |
| Disease | collagen disease (implicated_via_orthology) | 2.89e-03 | 12 | 200 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | sialate O-acetylesterase measurement | 2.89e-03 | 12 | 200 | 2 | EFO_0803073 | |
| Disease | Congenital muscular dystrophy | 2.89e-03 | 12 | 200 | 2 | cv:C0699743 | |
| Disease | Childhood Medulloblastoma | 3.10e-03 | 43 | 200 | 3 | C0278510 | |
| Disease | liver fat measurement | 3.10e-03 | 43 | 200 | 3 | EFO_0010821 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QLEGLPPETKVTIQV | 491 | Q86YH2 | |
| LQGSAAVEKIPLIPS | 191 | Q9BV23 | |
| PILDTNALQGEVKPV | 561 | P30154 | |
| EQLGTEIKPIPSNID | 451 | P26196 | |
| LLLLQPGEPSSEVKV | 26 | Q6UXG8 | |
| TLERKTPIQILGQEP | 1061 | Q4VCS5 | |
| DSEPQKVIKLGVLPV | 1056 | O15013 | |
| VTPEAASLGTVIKPL | 56 | Q9NYV4 | |
| PTIGSNVEEIILPKT | 46 | A6NH57 | |
| PEGLTLLVPDIQKTA | 4471 | Q9NR09 | |
| DLINKIETTVPPSGL | 526 | P26358 | |
| LDTQGLLQPEKPIVL | 476 | P20815 | |
| VPAIINPLDGTEKIA | 226 | Q96RQ1 | |
| PENGLTLSLTEPVVI | 111 | Q9ULV4 | |
| KGTPVIPLLTSVLLD | 381 | Q8TAV3 | |
| IKGPSLDIDTPDVNI | 4421 | Q09666 | |
| IPNIVAELTGDNIPK | 91 | P05408 | |
| LDKNLLEISGPETVP | 176 | Q9H444 | |
| LPVTSPLGIAVIKNL | 2536 | Q8TDJ6 | |
| VIRVPPEKVDLGETI | 251 | Q9BYV7 | |
| LSSVPVGLPVDLQEL | 171 | O43155 | |
| LVKPALPDGSLVIQA | 366 | Q13625 | |
| PLIAIINSPGKEELQ | 496 | Q2TB18 | |
| AQKIPETSLSVPLLG | 291 | Q04844 | |
| LPIGRDKVELEVTLP | 106 | Q9UKV8 | |
| PVVELSKVPLVQRGS | 671 | P25098 | |
| KNLLSITEDPEVGTP | 806 | Q9UPQ7 | |
| EPALVLGPLKSVQEL | 691 | P69849 | |
| PSTPIILVGTKLDLR | 106 | P15153 | |
| PNTPIILVGTKLDLR | 106 | P63000 | |
| PLKEPLTIQVLTVGN | 816 | Q9UHI8 | |
| LKPLLSGSIPVEQFV | 581 | Q9NV88 | |
| ILADLGSIKTPIDPE | 671 | Q9Y5G8 | |
| LLPQSGDPLIQVKEE | 61 | Q9ULG1 | |
| LEIPEQSLKLIPLVS | 76 | O60393 | |
| IPVGQIVTIKPLSED | 1456 | O94822 | |
| PSLTPIEVIVVLGKE | 271 | Q16654 | |
| PLLITQDLLETKGDP | 821 | Q9Y5G9 | |
| LEQSIVSKLGPLPRI | 631 | Q5VWQ8 | |
| SLIGALIPEPEVKIE | 16 | Q9NWM8 | |
| KIVGNTKVLEIPLEP | 491 | Q13469 | |
| KPAPDITILLSGQTI | 166 | O60500 | |
| EIEVTPSALKLGTPL | 121 | Q8TEW8 | |
| EPALVLGPLKSVQEL | 691 | Q5JPE7 | |
| PIDDLIKSGILPILV | 106 | O00505 | |
| VKVLGLPTQEPALGT | 136 | P20151 | |
| IPLSGEAPKTDILVE | 401 | Q2VYF4 | |
| VLKGLTVPIASIDIP | 206 | Q8NCW5 | |
| KEPAILVGPENLTLT | 236 | Q8IVU1 | |
| GDIQVVSLPLLKPQV | 871 | Q6P1M3 | |
| TEVLQLLSPPGIKIT | 116 | Q9UDY8 | |
| EAVKSVLLVVLPLPA | 806 | Q9HBX8 | |
| EELQNGLTPLLIVTP | 4491 | O95714 | |
| VLISLLDKPEIGPQV | 366 | Q9Y3R5 | |
| LGVLKESVQLNLAPP | 1786 | Q9Y3R5 | |
| PKQLNPIFGEILELS | 1291 | A9Z1Z3 | |
| VKTPESEGNPLLEQL | 146 | Q8WYK2 | |
| SKVTVNPGLLVPLDV | 56 | Q6KB66 | |
| GLLQPEKPVVLKVES | 481 | P08684 | |
| NLTLIDLPGITKVPV | 131 | Q9UQ16 | |
| GKDQPIILVLLDITP | 31 | P40925 | |
| EVQPLLKLGQPVSAV | 386 | Q9ULL4 | |
| GLNVIGIPSEIISPK | 146 | Q8NCN5 | |
| VIPDDPLVLLTQGKV | 326 | Q5XG92 | |
| LLNIGPTKDGLIVPI | 336 | P04066 | |
| SKLSVIPQDPVLLSG | 1216 | Q96J66 | |
| GSIDQSVLKELPPEL | 1041 | Q6KC79 | |
| EPALVLGPLKSVQEL | 691 | Q15155 | |
| ILGVPSLEEVINPKQ | 201 | Q5TB30 | |
| VALISPTVLKENGIP | 246 | Q6B0I6 | |
| IPEGIPIETKILDLS | 51 | Q7L985 | |
| TLPTGVPILLELDEN | 211 | P07738 | |
| ILVGLTDDPELQIPL | 11 | Q96R08 | |
| SGPEEPLVVQLAKTE | 306 | Q9HC73 | |
| ITPLLPAISGEKIAE | 191 | Q2PPJ7 | |
| NLTLIDLPGITKVPV | 131 | P50570 | |
| PGEVLEKDITPLQVV | 101 | Q14764 | |
| ADIQIVVDKSPLPLG | 71 | Q96EY5 | |
| LIDIKDTLPVGFIPI | 116 | Q9H7P6 | |
| EGVPLTPKANLLTTE | 91 | Q9NZB8 | |
| PQLVKLLGASELPIV | 296 | P52292 | |
| EIIPSSSKVIPLIGE | 301 | P30532 | |
| IKRGIISALLVPPET | 156 | P04114 | |
| IALGIPLPEIKNVVS | 741 | P31327 | |
| IVTLEPPKLEEIGNQ | 106 | Q9ULG6 | |
| GPNIITLADIVKDPV | 91 | Q8NEV1 | |
| LELVATVAKEPGPIA | 1106 | Q14674 | |
| PSEALELVGTDILPK | 671 | Q8N6C5 | |
| ELVGTDILPKPVISA | 676 | Q8N6C5 | |
| VPFLLVGKTTEPLIS | 4071 | Q4G0P3 | |
| VIPTDPQVLSKLGEL | 581 | Q13099 | |
| LIDPKDLDTTPVVNG | 461 | P33261 | |
| DPTGVLELPKELSEI | 341 | Q16254 | |
| IPGELPLVQELTSTL | 81 | Q9H7D0 | |
| STPIIFKEQGLTLPL | 76 | P51587 | |
| EGLTKLPFTIPELVQ | 91 | O75460 | |
| LLGVVGTDVPVKELL | 496 | Q8IZS8 | |
| PGDPQLIALIVEQLK | 46 | Q96IK1 | |
| DPIPKVINTDLEIVG | 241 | Q96SY0 | |
| PPGSQELELVESLLK | 191 | Q96A19 | |
| VLTPKVPEGDVTVIL | 56 | P18507 | |
| TPITGPLLALKEEDQ | 426 | Q6NUI2 | |
| GEQPLQLTTKPDLLA | 356 | O00257 | |
| STGPKAPITDIAIII | 36 | Q5VZ89 | |
| QSILGEKVPDLIVIP | 41 | Q96GE4 | |
| GPNIITLADIVKDPV | 91 | P68400 | |
| QVTVDGLEVLIPKDP | 221 | O75072 | |
| VDGPDPENIILILKT | 1361 | O75165 | |
| SVGPLPKSLEDLQLT | 131 | P51884 | |
| TPVAIKIIAIEGPDL | 506 | Q8TF76 | |
| LTLKEQPTQLELPEG | 256 | P42701 | |
| LFPLEDKIPVLGTNS | 41 | Q8N8F7 | |
| GILENSIKITNEPPT | 4006 | Q9NYC9 | |
| GITLTPKQAQELGIP | 1276 | A6NE01 | |
| AGVLPVEVQPLLLSD | 56 | Q8TDG4 | |
| PLVIKTGKPLLEEEI | 181 | Q6UWU4 | |
| GTLFTVELLPKQLPD | 2086 | Q9BYK8 | |
| EKVDVVLGPIQLQTP | 2391 | Q9UGM3 | |
| PEPLTGLLEQVVATL | 336 | Q5VWM4 | |
| QPPKVSEGKDVLLLV | 41 | Q00888 | |
| QPPKVSEGKDVLLLV | 41 | Q9UQ72 | |
| TPPGKEVTRLTLELE | 541 | Q8IX30 | |
| EGLLKLISPEELPAQ | 226 | Q9UDX4 | |
| LLPETKGIALPETVD | 516 | O75751 | |
| TPEPGSETLKLQQLV | 541 | Q9UJQ4 | |
| VPLEDLVGIISLPLQ | 2461 | P21817 | |
| TKPTPLILDEQGRTV | 251 | O43395 | |
| ILEPLLAGEPLVSTV | 571 | Q8N309 | |
| TFVLTPELSPGKLQV | 631 | Q96DY7 | |
| DELAVLPVVKVLPSG | 2176 | Q12923 | |
| KILESTLPGTVIPLG | 141 | Q9Y5E6 | |
| TAELPPLKNGEVLLE | 26 | Q14914 | |
| LSKLLVVGITDPDPD | 656 | P42345 | |
| KGPTPAILESLISIN | 1406 | P42345 | |
| PVLLEVLPKQAALTV | 1031 | Q6ZUA9 | |
| NEPLPEIKSIGDQII | 971 | Q92834 | |
| LRKLGPVTETETQLP | 251 | O75691 | |
| LPKSDLIPEGVVLVD | 276 | Q68CJ6 | |
| LPGEVTFLPLNKLDV | 581 | Q9UQE7 | |
| QPGLVIDLETTSLPV | 441 | P42224 | |
| VENIGPLPITVSSLK | 771 | A2VDJ0 | |
| TEKLGEKQLPILSVP | 1211 | A0AVI2 | |
| GTISLSKDLELPIIP | 1071 | Q6T4R5 | |
| EVQITEEKPLLPGQT | 6 | Q9UN36 | |
| QPPKVSEGKDVLLLV | 41 | Q00887 | |
| LQLKIAGAPEPLTVT | 316 | Q05397 | |
| PIITTQVTIPKDLAG | 386 | P61978 | |
| PETSVLVLRKPGINV | 921 | Q14697 | |
| TNVIPDILIIPVGIS | 341 | Q9HCL2 | |
| EPQVKIRGIIPETAT | 596 | Q8NEB9 | |
| TSVPQELLVTVVKPG | 996 | Q96PQ0 | |
| ELLVTVVKPGLPTLA | 1001 | Q96PQ0 | |
| PSPLTGKVNQLELIL | 1651 | Q9P2F8 | |
| NLTFEGPLPEKIELL | 401 | Q9HAT2 | |
| PEIAGLTPSQALEII | 291 | Q9BSE5 | |
| QPPKVSEGKDVLLLV | 41 | Q13046 | |
| EAFTIPLIPLGLKET | 106 | Q8IUC4 | |
| GALVPPAALISIIQK | 41 | Q9BZK7 | |
| TSPVGQLLPEVIIDK | 661 | P35498 | |
| GIKEESVPLSILQTP | 121 | P36956 | |
| ELQPVIPSLKLGETS | 1241 | Q13023 | |
| PLLPSKVDLQQVTII | 36 | Q0VFZ6 | |
| TVVNKGSLLEDVVPP | 246 | O14967 | |
| TGKELPDSQLVQPLV | 66 | O43529 | |
| DGRKLIPVETLTPEI | 321 | Q9BPX3 | |
| IDIPPGAVLENKIVS | 486 | Q16851 | |
| TEAPQGIPELIELLT | 196 | P57772 | |
| TEIVPVGEALLENPK | 471 | Q8TDR2 | |
| PGQSIDLVALLQKPV | 286 | Q5T6F2 | |
| PKGLVDNILPLTLEE | 576 | Q5W0Q7 | |
| SLTPVKELKEPVGQI | 3011 | Q8IZQ1 | |
| GILAVEQNKVLIPPT | 3031 | Q8IZQ1 | |
| GTIVKIEPPDLALTE | 231 | Q9Y5T5 | |
| PRLPGETLITDKEVI | 36 | Q13496 | |
| GLEQLLPELKVRTPT | 261 | Q96AN5 | |
| ITLLKPGLEQPEVEA | 341 | Q03426 | |
| TEDLVGIISIPLKLP | 2326 | Q15413 | |
| PPTEQDLTKLLLEGQ | 796 | P42226 | |
| KEVQQLLPEPVLGAT | 406 | Q8TB22 | |
| LIAGKLQESVPDPEL | 46 | Q96S82 | |
| TGIEPLPGENKILVT | 746 | Q5JSH3 | |
| PTIQEKGAVLPQEIS | 1251 | Q8IZH2 | |
| IELLKISVIELPLPS | 351 | Q9BTF0 | |
| QPILEKHGLSPLEVV | 401 | O43566 | |
| EAFTVPLIPLGLKET | 21 | A8MT19 | |
| DVGLVVIPLVKSPNV | 406 | Q8TCU3 | |
| ESGLQIQKSPEPEVL | 286 | Q12888 | |
| ITDPQTGLCLLPLKE | 4246 | Q15149 | |
| GEPITVNPALVSLKD | 796 | Q9ULD9 | |
| DSILVLQSLPGKQLP | 131 | Q9NQH7 | |
| QEPILITDLGLIQPI | 621 | Q9UL36 | |
| GALLTPKTEPEELAV | 896 | Q8N1G0 | |
| GVLFSPLLPAVQIIK | 606 | Q7Z403 | |
| EPIQELLVTHGKVPT | 56 | O75800 | |
| QPPKVSEGKDVLLLV | 41 | P11465 | |
| EGSLQPIIKTEGPTL | 686 | Q15063 | |
| IIPGLNETTVKLPAS | 276 | Q7Z7G0 | |
| TGTPLERIETDIKQP | 746 | Q7Z7G0 | |
| DLLTALGKIEPVFIP | 481 | Q5TAX3 | |
| LAVLQDEAGILPIPT | 56 | Q96GX1 | |
| ELIQLVPPVGETLST | 86 | Q9NWH7 | |
| LGLSIPKPDVISLLE | 46 | A8MQ14 | |
| GELELEPNSKLVLPT | 1391 | Q9BVV6 | |
| LEGLTKVVDPSQLTP | 186 | O75962 | |
| LDIIPASIPGSEVKL | 1261 | O75962 | |
| IKELFPTGKQLEPLV | 196 | Q96JC1 | |
| VLIKTVDVLPEGVEP | 2356 | Q9Y493 | |
| GTPPSDLIEIQVVKV | 36 | Q8NCA9 | |
| PIDDLIKSGILPILV | 106 | O00629 | |
| QLKGIDPPTLDQIVS | 76 | Q2WGJ6 | |
| QEKLENISLPPGLSI | 2051 | Q9NR99 | |
| IVPSLVSGNTELIPK | 256 | Q12879 | |
| LDLPLEIQPLTVGVN | 56 | Q14957 |